Atai Life Sciences Nv Stock Ownership - Who owns Atai Life Sciences Nv?

Insider buying vs selling

Have Atai Life Sciences Nv insiders been buying or selling?
Florian BrandCo-Founder Chief Executive Officer2023-09-1340,000$1.45
Apeiron Investment Group Ltd10% Owner2023-03-291,214,297$1.32
Florian BrandCo-Founder Chief Executive Officer2023-03-2970,000$1.48

1 of 1

ATAI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATAI insiders and whales buy or sell their stock.

ATAI Shareholders

What type of owners hold Atai Life Sciences Nv stock?
Apeiron Investment Group Ltd20.41%33,885,999$43.04MInsider
Christian Angermayer16.75%27,805,200$35.31MInsider
Blackrock Inc1.48%2,459,911$3.12MInstitution
Morgan Stanley1.27%2,114,437$2.69MInstitution
Millennium Management LLC0.67%1,108,145$1.41MInstitution
Cerity Partners LLC0.56%924,999$1.17MInstitution
State Street Corp0.53%878,220$1.12MInstitution
Brown University0.43%718,500$912.50kInstitution
Bank Of America Corp0.34%561,510$713.12kInstitution
Mirae Asset Global Investments Co Ltd0.33%544,311$691.27kInstitution

1 of 3

ATAI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATAI9.14%37.55%Net BuyingNet Buying
RENB2.35%97.65%Net Buying
VSTM24.78%75.22%Net SellingNet Selling
ALLK44.48%55.52%Net SellingNet Selling
ACRV49.62%50.38%Net Buying

Atai Life Sciences Nv Stock Ownership FAQ

Who owns Atai Life Sciences Nv?

Atai Life Sciences Nv (NASDAQ: ATAI) is owned by 9.14% institutional shareholders, 37.55% Atai Life Sciences Nv insiders, and 53.32% retail investors. Apeiron Investment Group Ltd is the largest individual Atai Life Sciences Nv shareholder, owning 33.89M shares representing 20.41% of the company. Apeiron Investment Group Ltd's Atai Life Sciences Nv shares are currently valued at $45.41M.

If you're new to stock investing, here's how to buy Atai Life Sciences Nv stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.